Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-17

Clinical Trial Update: Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial [Phase 1, Phase 2]

View source ↗

Summary

An N-of-1 clinical trial investigating prucalopride and buspirone for dyspepsia, completed in Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone (buspirone)
  • PRUCALOPRIDE (Prucalopride)

Snippet

Sponsor: Universidade de Passo Fundo | Conditions: Dyspepsia | Phase 1, Phase 2 | Status: COMPLETED